2DRx SOP - LloydsPharmacy

More documents

Recommendations

Info

• If a customer’s prescription were to be altered (e.g. dose alteration) during the period of a repeatable prescription the prescriber should issue a replacement repeatable prescription with the appropriate number of batch issues. • If the prescriber wishes to discontinue an existing treatment from an ongoing repeatable set of batch prescriptions, the pharmacist can still dispense any other medications required on these batches provided they mark the discontinued item as not dispensed and score a line through the item. • An item that requires regular monitoring e.g. Methotrexate can legally be prescribed on repeat dispensing prescriptions. Clinically the pharmacist would have to be sure that the patient is on a stable dose and appropriate monitoring arrangements are in place. • It is a legal requirement to comply with the dispensing intervals specified by the prescriber. This should be discussed with the patient and if there are concerns with the dispensing interval specified this should be discussed with the prescriber. The prescriber is not legally required to specify a dispensing interval. 2DRx Standard Operation Procedure July 2011 Page 50
Practical Issues • It is the responsibility of all employees involved with the dispensing process to ensure that the correct procedures are followed and that the customer receives a seamless and high quality dispensing service. • The filing box should be checked on a monthly basis and any repeatable prescriptions where the expiry date has been reached prior to the entire batch issues being dispensed should be forwarded to HSW, at the end of the month. The pharmacy copy of the Customer Record Card should be crossed through and the date that the repeatable prescription was sent to HSW and number of batch issues remaining detailed in the comments column. • There may be some variations to the prescription filing requirements as detailed on the end of month form required by HSW. It is important to ensure that any new procedures regarding repeat dispensing prescriptions are understood and followed. • Due to Clinical Governance requirements, any local variations must be agreed with and kept on record by the Pharmacy Superintendent’s Office. To do this, contact your Area Manager or Cluster Lead Manager. • All completed Customer Record Cards should be retained for six months after completion. At the end of this six month period, the record card should be disposed of following the current company policy for dealing with confidential waste ~ under NO circumstances should any card carrying customer details be disposed of in normal pharmacy waste. • Items dispensed within the repeat dispensing scheme should be included within your Prescription Collection Service (PCS) figures when reported on the MRS. • The Pharmacist Manager should work closely with the prescriber to communicate changes to the customer’s medication, monitor the customer’s use of their medication and highlight any patient safety issues. • Dispensers and Healthcare Assistants, as well as Pre-Registration students, must be properly trained to operate the system and give full support to the Pharmacist. • Locum pharmacists should be made aware of the Repeat Dispensing system in operation and directed to the relevant SOP. • The repeatable prescription will detail the specific number of issues the prescriber wishes to issue from the prescription and, if appropriate, the dispensing interval, i.e. weekly, monthly, quarterly, as well as the normal information relating to patient’s name and address, date of birth, etc. • The batch issues will not be signed by the prescriber, but will be used for reimbursement purposes. The prescriber is only required sign the repeatable prescription. • The pharmacist will issue the number of batch issues as required for each repeatable prescription. • The CoMPaSS system differentiates between the repeat WP10SS forms and other types of WP10SS forms and will indicate on the form when repeat dispensing is required as well as linking the designated number of batch issues. • The repeatable prescription (RA) must remain in the pharmacy. • The pharmacist will not make any changes to the prescription, dose, strength, formulation, etc., but will refer back to the prescriber. Any interventions or referrals which are deemed to be clinically significant should be recorded on the Intervention and Referral Form. 2DRx Standard Operation Procedure July 2011 Page 51
Page 1 and 2: 2DRx Standard Operating Procedure T
Page 3 and 4: Refer to pharmacist Return Rx to su
Page 5 and 6: Return to prescriber No Legal requi
Page 7 and 8: 2DRx Standard Operation Procedure J
Page 9 and 10: Associated Risks The prescription m
Page 11 and 12: Pharmaceutical Assessment Objective
Page 13 and 14: Interventions and Problem Solving (
Page 15 and 16: Interventions and Problem Solving O
Page 17 and 18: Follow Owings SOP No Picking With r
Page 19 and 20: Obtain copy of P.I.L if not availab
Page 21: Detach customer copy when prescript
Page 24 and 25: Owings for Schedule 2 and 3 Control
Page 26 and 27: Associated Risks The picking proces
Page 28 and 29: The electronic endorser must be use
Page 30 and 31: Accuracy Check (1) If the prescript
Page 32 and 33: Accuracy Check Objectives This SOP
Page 34 and 35: Bagging Up Place items in bag, coun
Page 36 and 37: Bagging Up Objectives This SOP is d
Page 38 and 39: Refer to pharmacist if appropriate
Page 40 and 41: Associated Risks Ensure the custome
Page 42 and 43: Process manually in CoMPaSS 2DRx -
Page 44 and 45: If as a result of the review any ch
Page 46 and 47: Accepting a Repeatable Prescription
Page 48 and 49: Processing a Repeatable Prescriptio
Page 52 and 53: • The pharmacy / dispensary staff
Page 54 and 55: A5 Customer Record Card for Pharmac
Page 56 and 57: Support Materials From Centurion Pa
Page 58: 2DRx Procedures Employee Declaratio

2DRx SOP - LloydsPharmacy

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?